Table 1.

Patient characteristics

Characteristic	All (n = 71)
Age (years)	71.3 ± 9.5
Female Gender	21 (29%)
Caucasian	71 (100%)
Weight at diagnosis (kg)	88.6 ± 17.9
BMI at diagnosis	29.81 ± 4.94
Weight change at 1 year after diagnosis	− 2.1 ± 4.3
BMI 1 yr post	29.1 ± 4.8
Smoking (any)	50 (70%)
Antifibrotic (any)	36 (51%)
Pirfenidone	19 (27%)
Nintedanib	17 (23%)
FVC at diagnosis (L)	2.9 ± 0.8
FVC % predicted	79.2 ± 19.4
DLCO at diagnosis (mL/min/mm Hg)	11.6 ± 4.7
Reflux disease	31 (44%)
Diabetes	13 (18%)
OSA	9 (13%)
Oxygen use	22 (31%)

BMI: body mass index; DLCO: diffusion limitation for carbon monoxide; FVC: forced vital capacity; OSA: obstructive sleep apnea